...Valeant acquired a 19.9% minority stake in Pelenova, a Brazilian tissue regeneration company, for less than...
...regeneration company, for less than $10 million in cash. Valeant received rights to all future Pelenova...
...of first refusal to acquire worldwide rights to future products. Valeant will have representation on Pelenova's...